Ferritin nanocages can deliver inhibitors of hyperactive protein kinases for a targeted treatment of breast cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216305%3A26620%2F19%3APU140020" target="_blank" >RIV/00216305:26620/19:PU140020 - isvavai.cz</a>
Alternative codes found
RIV/62156489:43210/19:43917141
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Ferritin nanocages can deliver inhibitors of hyperactive protein kinases for a targeted treatment of breast cancer
Original language description
This project was focused on targeted chemotherapy based on ferritin nanocarriers with encapsulated various types of tyrosine kinase inhibitors. Then this nanoconstruct is surface-modified by folic acid, with the aim to achieve specific targeting to folate receptor overexpressed in targeted breast cancer cell line.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
—
OECD FORD branch
10602 - Biology (theoretical, mathematical, thermal, cryobiology, biological rhythm), Evolutionary biology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
MENDELNET 2019: PROCEEDINGS OF 26TH INTERNATIONAL PHD STUDENTS CONFERENCE
ISBN
978-80-7509-688-3
ISSN
—
e-ISSN
—
Number of pages
5
Pages from-to
627-631
Publisher name
Neuveden
Place of publication
Neuveden
Event location
Brno
Event date
Nov 6, 2019
Type of event by nationality
CST - Celostátní akce
UT code for WoS article
000576735500113